ZENTIVA S.A. (SCD) - Net Assets

Latest as of March 2025: RON1.50 Billion RON ≈ $343.69 Million USD

Based on the latest financial reports, ZENTIVA S.A. (SCD) has net assets worth RON1.50 Billion RON (≈ $343.69 Million USD) as of March 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RON1.85 Billion ≈ $424.20 Million USD) and total liabilities (RON350.60 Million ≈ $80.50 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read SCD total liabilities for a breakdown of total debt and financial obligations.

Key Net Assets Metrics

Metric	Value
Current Net Assets	RON1.50 Billion
% of Total Assets	81.02%
Annual Growth Rate	15.47%
5-Year Change	83.56%
10-Year Change	N/A
Growth Volatility	3.81

ZENTIVA S.A. - Net Assets Trend (2019–2024)

This chart illustrates how ZENTIVA S.A.'s net assets have evolved over time, based on quarterly financial data. Also explore total assets of ZENTIVA S.A. for the complete picture of this company's asset base.

Annual Net Assets for ZENTIVA S.A. (2019–2024)

The table below shows the annual net assets of ZENTIVA S.A. from 2019 to 2024. For live valuation and market cap data, see SCD market cap overview.

Year	Net Assets	Change
2024-09-30	RON1.44 Billion ≈ $331.01 Million	+21.01%
2023-09-30	RON1.19 Billion ≈ $273.53 Million	+19.20%
2022-09-30	RON999.35 Million ≈ $229.47 Million	+12.19%
2021-09-30	RON890.77 Million ≈ $204.54 Million	+13.42%
2020-09-30	RON785.36 Million ≈ $180.33 Million	+11.88%
2019-09-30	RON702.00 Million ≈ $161.19 Million	--

Equity Component Analysis

This analysis shows how different components contribute to ZENTIVA S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 139.4% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (September 2024)

Component	Amount	Percentage
Retained Earnings	RON1.08 Billion	75.02%
Other Components	RON360.10 Million	24.98%
Total Equity	RON1.44 Billion	100.00%

ZENTIVA S.A. Competitors by Market Cap

The table below lists competitors of ZENTIVA S.A. ranked by their market capitalization.

Company	Market Cap
Hichain Logistics Co Ltd SHE:300873	$723.48 Million
GKHT Medical Technology Co. Ltd. A SHE:301370	$723.76 Million
Montrose Environmental Grp NYSE:MEG	$724.07 Million
Sichuan Tianyi Comheart Telecom Co Ltd Class A SHE:300504	$724.18 Million
Janus International Group Inc NYSE:JBI	$723.28 Million
Beijing Career International Co Ltd SHE:300662	$723.14 Million
Bangkok Chain Hospital Public Company Limited BK:BCH	$722.94 Million
G City Ltd TA:GCT	$722.78 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in ZENTIVA S.A.'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 1,191,262,465 to 1,441,585,389, a change of 250,322,924 (21.0%).
Net income of 250,510,124 contributed positively to equity growth.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	RON250.51 Million	+17.38%
Other Changes	RON-187.20K	-0.01%
Total Change	RON-	21.01%

Book Value vs Market Value Analysis

This analysis compares ZENTIVA S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.19x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 4.49x to 2.19x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2019-09-30	RON1.01	RON4.52	x
2020-09-30	RON1.13	RON4.52	x
2021-09-30	RON1.28	RON4.52	x
2022-09-30	RON1.43	RON4.52	x
2023-09-30	RON1.71	RON4.52	x
2024-09-30	RON2.07	RON4.52	x

Capital Efficiency Dashboard

This dashboard shows how efficiently ZENTIVA S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 17.38%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 22.49%
• Asset Turnover: 0.64x
• Equity Multiplier: 1.20x
Recent ROE (17.38%) is above the historical average (11.66%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2019	6.23%	7.30%	0.59x	1.45x	RON-26.45 Million
2020	8.36%	11.76%	0.54x	1.32x	RON-12.90 Million
2021	11.87%	14.90%	0.68x	1.18x	RON16.67 Million
2022	9.95%	13.09%	0.63x	1.21x	RON-470.25K
2023	16.17%	20.20%	0.64x	1.26x	RON73.49 Million
2024	17.38%	22.49%	0.64x	1.20x	RON106.35 Million

Industry Comparison

This section compares ZENTIVA S.A.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $611,812,622
Average return on equity (ROE) among peers: 12.08%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
ZENTIVA S.A. (SCD)	RON1.50 Billion	6.23%	0.23x	$723.41 Million
Antibiotice Ia (ATB)	$932.07 Million	5.55%	0.49x	$301.21 Million
Biofarm Bucure (BIO)	$291.55 Million	18.61%	0.28x	$329.20 Million

About ZENTIVA S.A.

RO:SCD Romania Drug Manufacturers - Specialty & Generic

Market Cap

$723.41 Million

RON3.15 Billion RON

Market Cap Rank

#10785 Global

#12 in Romania

Share Price

RON4.52

Change (1 day)

+0.00%

52-Week Range

RON4.52 - RON4.52

All Time High

RON4.52